ReviewClinical rheumatology2013

Safety of tumor necrosis factor inhibitors use for rheumatoid arthritis and ankylosing spondylitis in Africa, the Middle East, and Asia: focus on severe infections and tuberculosis.

Mohammed Hammoudeh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.